Patents-Review.com
ClassID:

21109 ⎘

A61K39/118 - CPC Classification

Classification description:

Medicinal preparations containing antigens or antibodies Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci

Recent Application in this class:
#1
20250339506
2025-11-06

COMPOSITIONS FOR USE IN TREATMENT OF CHLAMYDIA

 #2
20250255951
2025-08-14

Vaccines against Chlamydia sp.

 #3
20250186573
2025-06-12

ATTENUATED MATURATION-DEFECTIVE CHLAMYDIA VACCINES

 #4
20250170236
2025-05-29

A NOVEL CATIONIC ADJUVANT COMPOSITION

 #5
20250108103
2025-04-03

OIL-BASED ADJUVANTS

 #6
20240299524
2024-09-12

Compositions for use in treatment of

#7
20240156938
2024-05-16

COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING HUMAN CHLAMYDIAL INFECTIONS AND DISEASES USING ATTENUATED ANIMAL CHLAMYDIA

 #8
20240156937
2024-05-16

BACERIOPHAGE VIRUS-LIKE PARTICLES VACCINES FOR CHLAMYDIA TRACHOMATIS INFECTIONS

 #9
20240139336
2024-05-02

COMPLEXES FOR DELIVERY OF ANTIGENIC PEPTIDES

 #10
20240131138
2024-04-25

CHLAMYDIA VACCINE BASED ON TARGETING MOMP VS4 ANTIGEN TO ANTIGEN PRESENTING CELLS

 #11
20240124532
2024-04-18

CHLAMYDIA TRACHOMATIS ANTIGENIC POLYPEPTIDES AND USES THEREOF FOR VACCINE PURPOSES

 #12
20240000913
2024-01-04

Oil-based adjuvants

 #13
20230355741
2023-11-09

Feline Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine

 #14
20230346907
2023-11-02

SEXUALLY TRANSMITTED DISEASE VACCINES

 #15
20230112697
2023-04-13

METHODS AND COMPOSITIONS RELATED TO THE NEXT GENERATION VACCINE

 #16
20220195013
2022-06-23

MULTI-EPITOPIC CONSTRUCT

 #17
20220160861
2022-05-26

Vaccine composition against Chlamydiaceae infections

 #18
20220008532
2022-01-13

Multivalent feline vaccine

 #19
20210252127
2021-08-19

Methods and compositions related to the next generation vaccine

 #20
20210213129
2021-07-15

NON-PSYCHOACTIVE CANNABINOIDS AS ADJUVANTS TO ENHANCE MUCOSAL IMMUNITY

 #21
20210205433
2021-07-08

Vaccines against Chlamydia sp.

 #22
20210170013
2021-06-10

Oil-based adjuvants

 #23
20210106668
2021-04-15

RECOMBINANT CHLAMYDIA-ACTIVATED B CELL PLATFORMS AND METHODS OF USE THEREOF

 #24
20210015914
2021-01-21

METHODS AND COMPOSITIONS RELATED TO ACCELERATED HUMORAL AFFINITY

 #25
20200384098
2020-12-10

Vaccine composition against infections

 #26
20200338186
2020-10-29

Feline calicivirus vaccine

 #27
20200331949
2020-10-22

D-glycero-B-D-heptose 1-phosphate (HMP) conjugates and use for targeted immune modulation

 #28
20200289635
2020-09-17

-activated B cell platforms and methods thereof

 #29
20200254088
2020-08-13

Multivalent feline vaccine

 #30
20200215179
2020-07-09

NANOPARTICLE-BASED COMPOSITIONS

 #31
20200188498
2020-06-18

Targeted gene disruption methods and immunogenic compositions

 #32
20200138935
2020-05-07

CHLAMYDIA NANOEMULSION VACCINE

 #33
20200129640
2020-04-30

Complexes for delivery of antigenic peptides

 #34
20200002408
2020-01-02

Recombinant gram negative bacteria and methods of generating and utilizing same

 #35
20190282685
2019-09-19

Chlamydia antigens

 #36
20190224298
2019-07-25

Platforms and methods for optimizing host antigen presentation and host antitumor and antipathogen immunity

 #37
20190209679
2019-07-11

Particulate formulations for enhancing growth in animals

 #38
20190201340
2019-07-04

METHODS FOR PRODUCING LIPOSOMES

 #39
20190099478
2019-04-04

Vaccines against sp

 #40
20190038737
2019-02-07

Oil-based adjuvants

 #41
20180369366
2018-12-27

Methods and compositions related to accelerated humoral affinity

 #42
20180296662
2018-10-18

Sexually transmitted disease vaccines

 #43
20180289792
2018-10-11

SEXUALLY TRANSMITTED DISEASE VACCINES

 #44
20180273608
2018-09-27

Multi-epitopic construct

 #45
20180214536
2018-08-02

Vaccine composition against Chlamydiaceae infections

 #46
20180092970
2018-04-05

CHLAMYDIA ANTIGENS

 #47
20180028642
2018-02-01

-activated B cell platforms and methods thereof

 #48
20180021423
2018-01-25

Methods and compositions for attenuated chlamydia as vaccine and vector

 #49
20170340751
2017-11-30

Artificial multi-antigen fusion protein and preparation and use thereof

 #50
20170252424
2017-09-07

Methods and compositions for vaccinating a subject for a sexually transmitted pathogen

 #51
20170081659
2017-03-23

Compositions and methods for immunodominant antigens

 #52
20170072051
2017-03-16

Particulate formulations for improving feed conversion rate in a subject

 #53
20170043005
2017-02-16

CHLAMYDIA ANTIGENS AND USES THEREOF

 #54
20170023586
2017-01-26

Compositions and methods for immunodominant antigens of

#55
20170021007
2017-01-26

Chlamydia vaccine

 #56
20160367655
2016-12-22

Immunogenic Compositions

 #57
20160346375
2016-12-01

Type III secretion injectisome proteins for treatment and prevention of chlamydial infections

 #58
20160193318
2016-07-07

Vaccine

 #59
20160158337
2016-06-09

Chlamydia antigens

 #60
20160067327
2016-03-10

OMV vaccines

 #61
20160045588
2016-02-18

CHLAMYDIA ANTIGEN COMPOSITIONS AND USES THEREOF

 #62
20160015798
2016-01-21

Attenuated chlamydia vaccine

 #63
20160008452
2016-01-14

Vault compositions for immunization

 #64
20160008451
2016-01-14

Nanoparticle-based compositions

 #65
20150313987
2015-11-05

Low Antigen-dose Immunization for Maximizing T-helper Cell 1 (Th1) Immunity Against a Pathogen

 #66
20150297706
2015-10-22

Particulate Vaccine Formulations for Inducing Innate and Adaptive Immunity

 #67
20150216967
2015-08-06

IC31 nanoparticles

 #68
20150202280
2015-07-23

Mutant Forms of Chlamydia HtrA

 #69
20150168401
2015-06-18

Compositions and methods for immunodominant antigens of

#70
20150140034
2015-05-21

Oil-based adjuvants

 #71
20150056241
2015-02-26

Compositions And Methods For Immunodominant Antigens

 #72
20150050312
2015-02-19

Bacterial vaccine

 #73
20150010591
2015-01-08

CHLAMYDIA ANTIGEN COMPOSITIONS AND USES THEREOF

 #74
20140377301
2014-12-25

Vault compositions for immunization

 #75
20140328880
2014-11-06

Modified pathogens for use as vaccines

 #76
20140275478
2014-09-18

Vaccines against Chlamydia sp.

 #77
20140242105
2014-08-28

Vaccines for

#78
20140093510
2014-04-03

Chlamydia antigens

 #79
20130344109
2013-12-26

Immunogenic compositions

 #80
20130251749
2013-09-26

METHODS AND COMPOSITIONS FOR CHLAMYDIAL ANTIGENS AS REAGENTS/STRATEGIES FOR DIAGNOSIS AND TREATMENT OF CHLAMYDIAL INFECTION AND DISEASE

 #81
20130224244
2013-08-29

Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD)

 #82
20130195907
2013-08-01

OMV vaccines

 #83
20130171238
2013-07-04

IMMUNOGENIC COMPOSITIONS FOR CHLAMYDIA TRACHOMATIS

 #84
20130156804
2013-06-20

Porin B (PorB) as a therapeutic target for prevention and treatment of infection by

#85
20130156775
2013-06-20

CHLAMYDIA TRACHOMATIS ANTIGENS

 #86
20130122037
2013-05-16

Vault compositions for immunization

 #87
20130078273
2013-03-28

Vault Compositions For Immunization

 #88
20130072398
2013-03-21

Compositions and methods for immunodominant antigens of

#89
20130045181
2013-02-21

Methods and Compositions for Chlamydial Antigens for Diagnosis and Treatment of Chlamydial Infection and Disease

 #90
20130034577
2013-02-07

Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of

#91
20120328644
2012-12-27

Low antigen-dose immunization utilizing overlapping peptides for maximizing T-helper cell 1 (Th1) immunity against a pathogen

 #92
20120308618
2012-12-06

1C31 nanoparticles

 #93
20120142555
2012-06-07

Compositions and methods for immunodominant antigens of

#94
20120141534
2012-06-07

Vault compositions for immunization against Chlamydia genital infection

 #95
20120135039
2012-05-31

Oral Vaccines for Producing Mucosal Immunity

 #96
20120135025
2012-05-31

CHLAMYDIA ANTIGENS AND USES THEREOF

 #97
20120134999
2012-05-31

Porin B (PorB) as a therapeutic target for prevention and treatment of infection by

#98
20120093851
2012-04-19

Chlamydia antigens

 #99
20120027793
2012-02-02

COMPOSITIONS COMPRISING CHLAMYDIA ANTIGENS

 #100
20120014982
2012-01-19

Methods and compositions for immunizing against infection

 #101
20120009220
2012-01-12

Low antigen-dose immunization for maximizing T-helper cell 1 (Th1) immunity against a pathogen

 #102
20110300206
2011-12-08

Vaccines against chlamydial infection

 #103
20110287087
2011-11-24

MODIFIED CATIONIC LIPOSOME ADJUVANS

 #104
20110268760
2011-11-03

vectored vaccines against and methods of use

 #105
20110245099
2011-10-06

Compositions and methods for immunodominant antigens of

#106
20110236484
2011-09-29

Genus-wide chlamydial peptide vaccine antigens

 #107
20110123491
2011-05-26

Methods and compositions for immunization against chlamydial infection and disease

 #108
20110110857
2011-05-12

MUTANT FORMS OF CHLAMYDIA HTRA

 #109
20110070266
2011-03-24

IMMUNOGENIC COMPOSITIONS FOR CHLAMYDIA TRACHOMATIS

 #110
20110059128
2011-03-10

VACCINE COMPOSITION FOR VACCINATING DOGS AGAINST CANINE INFECTIOUS RESPIRATORY DISEASE (CIRD)

 #111
20110027321
2011-02-03

Chlamydia Vaccine Comprising HtrA Polypeptides

 #112
20110014210
2011-01-20

Chlamydia vaccine

 #113
20100316662
2010-12-16

Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of

#114
20100310593
2010-12-09

Vaccines Against Chlamydia Infection

 #115
20100297164
2010-11-25

Chlamydial antigens

 #116
20100255002
2010-10-07

Immunogenic compositions for chlamydia trachomatis

 #117
20100203075
2010-08-12

CHLAMYDIA ANTIGENS

 #118
20100189738
2010-07-29

Porin B (PorB) as a therapeutic target for prevention and treatment of infection by

#119
20100172927
2010-07-08

Vaccines Against Chlamydial Infection

 #120
20100119549
2010-05-13

Chlamydial antigens as reagents for diagnosis and treatment of chlamydial infection and disease

 #121
20100119535
2010-05-13

Compositions and methods for immunodominant antigens

 #122
20100112002
2010-05-06

Modified pathogens for use as vaccines

 #123
20100098697
2010-04-22

antigens

 #124
20100041023
2010-02-18

Inactivated FCV vaccines

 #125
20090304751
2009-12-10

Vault compositions for immunization against chlamydia genital infection

 #126
20090304722
2009-12-10

antigens for vaccine and diagnostic use

 #127
20090285847
2009-11-19

Compositions and methods for immunodominant antigens of

#128
20090252765
2009-10-08

BACILLE CALMETTE-GUERIN (BCG)-BASED ANTI-ATHEROMA VACCINE AND METHODS OF USE THEREOF

 #129
20090214570
2009-08-27

Methods and compositions for immunizing against infection

 #130
20090162837
2009-06-25

Inactivated FCV vaccines

 #131
20090142376
2009-06-04

polypeptides and corresponding DNA fragments and uses thereof

 #132
20090098165
2009-04-16

Methods and compositions for immunization against chlamydial infection and disease

 #133
20090047283
2009-02-19

COMPOUNDS AND METHODS FOR TREATMENT AND DIAGNOSIS OF CHLAMYDIAL INFECTION

 #134
20090028891
2009-01-29

Chlamydia Antigens and Uses Thereof

 #135
20090022755
2009-01-22

VACCINES AGAINST CHLAMYDIAL INFECTION

 #136
20080305112
2008-12-11

Immunisation against chlamydia trachomatis

 #137
20080220018
2008-09-11

VACCINE COMPOSITION FOR VACCINATING DOGS AGAINST CANINE INFECTIOUS RESPIRATORY DISEASE(CIRD)

 #138
20080199474
2008-08-21

Porin B (PorB) as a therapeutic target for prevention and treatment of infection by

#139
20080199456
2008-08-21

COMPOUNDS AND METHODS FOR TREATMENT AND DIAGNOSIS OF CHLAMYDIAL INFECTION

 #140
20080176797
2008-07-24

COMPOUNDS AND METHODS FOR TREATMENT AND DIAGNOSIS OF CHLAMYDIAL INFECTION

 #141
20080166376
2008-07-10

Immunization Against Chlamydia Infection

 #142
20080160027
2008-07-03

CHLAMYDIA PNEUMONIAE VACCINE AND METHODS FOR ADMINISTERING SUCH A VACCINE

 #143
20080113933
2008-05-15

60 Kda CRMP antigens and vaccine uses

 #144
20080112965
2008-05-15

Chlamydia OMP antigen

 #145
20080102112
2008-05-01

CHLAMYDIA VACCINES

 #146
20080025998
2008-01-31

Method and compositions for vaccination comprising nucleic acid and/or polypeptide sequence of chlamydia

 #147
20080019994
2008-01-24

Immunization Against Chlamydia Infection

 #148
20070292437
2007-12-20

PMP proteins, gene sequences and uses thereof

 #149
20070292425
2007-12-20

PMP proteins, gene sequences and uses thereof

 #150
20070196392
2007-08-23

Development of a sp. vaccine strain

 #151
20070149474
2007-06-28

Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of chlamydia

 #152
20070098739
2007-05-03

Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD)

 #153
20060233826
2006-10-19

Porin B (PorB) as a therapeutic target for prevention and treatment of infection by

#154
20060216308
2006-09-28

Immunisation against

#155
20060188516
2006-08-24

Chlamydia trachomatis antigens

 #156
20060160101
2006-07-20

Inactivated FCV vaccines

 #157
20060034871
2006-02-16

Immunogenic compositions for Chlamydia trachomatis

 #158
20050281847
2005-12-22

Vaccine composition

 #159
20050266016
2005-12-01

Porin B (PorB) as a therapeutic target for prevention and treatment of infection by

#160
20050232948
2005-10-20

Process for making an adjuvanted vaccine comprising host albumin

 #161
20050232941
2005-10-20

Compounds and methods for treatment and diagnosis of chlamydial infection

 #162
20050220805
2005-10-06

outer membrane protein (OMP) and vaccine uses of the protein

 #163
20050208123
2005-09-22

Chylamydia vaccine

 #164
20050186266
2005-08-25

antigens and corresponding DNA fragments and uses thereof

 #165
20050152873
2005-07-14

Agents for enhancing the immune response

 #166
20050106162
2005-05-19

Immunisation against chlamydia trachomatis

 #167
20050095254
2005-05-05

DNA immunization against infection

 #168
20050084499
2005-04-21

Compounds and methods for treatment and diagnosis of chlamydial infection

 #169
20050069942
2005-03-31

Chlamydia antigens and corresponding DNA fragments and uses thereof

 #170
20050065106
2005-03-24

Immunogenic compositions for protection against Chlamydial infection

 #171
20050002944
2005-01-06

Chlamydia antigens and corresponding DNA fragments and uses thereof